SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-13-090955
Filing Date
2013-12-18
Accepted
2013-12-18 16:09:32
Documents
1
Group Members
ARBORETUM INVESTMENT MANAGER IIA, LLCARBORETUM VENTURES II, LPARBORETUM VENTURES IIA, LPARBORETUM VENTURES, INC.JAN L. GARFINKLETIMOTHY B. PETERSEN

Document Format Files

Seq Description Document Type Size
1 SC 13G a13-26601_1sc13g.htm SC 13G 261701
  Complete submission text file 0001104659-13-090955.txt   263593
Mailing Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170 734-862-4840
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87536 | Film No.: 131285286
SIC: 2834 Pharmaceutical Preparations

Mailing Address MARKET PLACE BUILDING 303 DETROIT STREET, SUITE 301 ANN ARBOR MI 48104
Business Address MARKET PLACE BUILDING 303 DETROIT STREET, SUITE 301 ANN ARBOR MI 48104 734-998-3688
Arboretum Investment Manager II, LLC (Filed by) CIK: 0001592722 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G